CASELLI, Emilia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.530
AS - Asia 4.607
EU - Europa 3.906
SA - Sud America 610
Continente sconosciuto - Info sul continente non disponibili 130
AF - Africa 88
OC - Oceania 10
Totale 17.881
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.331
SG - Singapore 1.378
CN - Cina 1.234
IT - Italia 1.067
GB - Regno Unito 815
SE - Svezia 506
VN - Vietnam 504
HK - Hong Kong 491
BR - Brasile 447
DE - Germania 365
BD - Bangladesh 217
RU - Federazione Russa 199
KR - Corea 190
FI - Finlandia 187
FR - Francia 167
UA - Ucraina 159
TR - Turchia 130
IN - India 113
CA - Canada 104
ID - Indonesia 69
BG - Bulgaria 66
JP - Giappone 61
BE - Belgio 60
NL - Olanda 57
MX - Messico 55
IE - Irlanda 50
PL - Polonia 47
ES - Italia 41
AR - Argentina 38
IQ - Iraq 35
RO - Romania 30
PK - Pakistan 28
EC - Ecuador 27
CO - Colombia 26
ZA - Sudafrica 23
AT - Austria 20
MA - Marocco 20
AE - Emirati Arabi Uniti 19
VE - Venezuela 19
CL - Cile 18
MY - Malesia 18
LT - Lituania 17
SA - Arabia Saudita 13
UZ - Uzbekistan 13
PE - Perù 12
KZ - Kazakistan 11
TW - Taiwan 11
AZ - Azerbaigian 9
JM - Giamaica 9
JO - Giordania 8
KE - Kenya 8
MD - Moldavia 8
PH - Filippine 8
PY - Paraguay 8
TN - Tunisia 8
AU - Australia 7
BO - Bolivia 7
CR - Costa Rica 7
IL - Israele 7
CH - Svizzera 6
AL - Albania 5
DZ - Algeria 5
ET - Etiopia 5
QA - Qatar 5
SC - Seychelles 5
TH - Thailandia 5
UY - Uruguay 5
CI - Costa d'Avorio 4
CZ - Repubblica Ceca 4
EG - Egitto 4
IR - Iran 4
LB - Libano 4
NI - Nicaragua 4
NO - Norvegia 4
NP - Nepal 4
PS - Palestinian Territory 4
BH - Bahrain 3
DK - Danimarca 3
GR - Grecia 3
GT - Guatemala 3
KG - Kirghizistan 3
PA - Panama 3
PT - Portogallo 3
BY - Bielorussia 2
CY - Cipro 2
DO - Repubblica Dominicana 2
EE - Estonia 2
GY - Guiana 2
HN - Honduras 2
HU - Ungheria 2
KW - Kuwait 2
LV - Lettonia 2
MK - Macedonia 2
MT - Malta 2
NZ - Nuova Zelanda 2
PR - Porto Rico 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
SV - El Salvador 2
AG - Antigua e Barbuda 1
Totale 17.733
Salva come PNG Salva come JPEG
Città #
Singapore 880
Santa Clara 816
Ashburn 796
Chandler 517
Hong Kong 476
Fairfield 475
Hefei 454
Woodbridge 448
Southend 419
San Jose 365
Council Bluffs 307
Jacksonville 306
Ann Arbor 263
Nyköping 262
Houston 243
London 212
Cambridge 209
Dearborn 206
Seattle 198
Beijing 193
Wilmington 190
Los Angeles 181
Modena 180
Ho Chi Minh City 149
Dallas 135
Helsinki 135
Seoul 130
The Dalles 118
Chicago 113
Hanoi 111
Berlin 108
New York 105
Milan 96
Princeton 61
Sofia 61
Lauterbourg 55
San Diego 54
Redwood City 52
Eugene 48
Shanghai 48
Des Moines 47
Dublin 47
São Paulo 47
Buffalo 45
Izmir 42
Jakarta 40
Moscow 40
Columbus 39
Frankfurt am Main 39
Salt Lake City 39
Tokyo 39
Brussels 38
Phoenix 38
Reggio Emilia 37
Warsaw 36
Bologna 33
Parma 33
Amsterdam 32
Atlanta 30
Orem 29
Mexico City 28
Munich 28
Yalova 28
Florence 27
Boardman 26
Brooklyn 23
Da Nang 22
Toronto 22
Chennai 21
Elk Grove Village 21
Tampa 21
Timisoara 21
Rome 20
Turin 20
Boston 19
Falls Church 19
Guangzhou 19
Menlo Park 19
Nuremberg 19
Washington 19
Haiphong 18
Pedara 18
Fuzhou 17
Montreal 17
Bremen 16
Fremont 16
Kent 16
San Francisco 16
Vancouver 16
Austin 15
Denver 15
Formigine 15
Seongnam 15
Dong Ket 14
Ghent 14
Dhaka 13
Norwalk 13
Redondo Beach 13
Rio de Janeiro 13
Draper 12
Totale 11.689
Salva come PNG Salva come JPEG
Nome #
A Common Mechanism Underlying Promiscuous Inhibitors from Virtual and High-Throughput Screening 991
1,2,3-Triazolylmethaneboronate: A Structure Activity Relationship Study of a Class of β-Lactamase Inhibitors against Acinetobacter baumannii Cephalosporinase 892
Click Chemistry in Lead Optimization of Boronic Acids as β-Lactamase Inhibitors 424
Chemo-enzymatic synthesis of levodropropizine 399
Biocatalytic asymmetric synthesis of (S)- and (R)-Timolol 393
Boronic acid transition state inhibitors active against KPC and other class a β-lactamases: Structure-activity relationships as a guide to inhibitor design 380
Deciphering the evolution of cephalosporin resistance to ceftolozane-tazobactam in pseudomonas aeruginosa 375
(S)-(+)-N-acetylphenylglycineboronic acid: A chiral derivatizing agent for Ee determination of 1,2-diols 351
Inhibiting the β-Lactamase of Mycobacterium tuberculosis (Mtb) with Novel Boronic Acid Transition-State Inhibitors (BATSIs) 345
Biochemical and structural analysis of inhibitors targeting the ADC-7 cephalosporinase of Acinetobacter baumannii 336
The β-Lactamase Inhibitor Boronic Acid Derivative SM23 as a New Anti-Pseudomonas aeruginosa Biofilm 336
Crystal structures of KPC-2 and SHV-1 β-lactamases in complex with the boronic acid transition state analog S02030 335
Acetamidomethaneboronic acids bearing the R1 side chains of beta-lactams as inhibitors of beta-lactamase enzymes 333
Boronic acid inhibitors of beta-lactamases as therapeutic agents in treatment of antibiotic-resistant infection diseases 321
Inhibition of Quorum Sensing-dependent biofilm formation and virulence factors in Pseudomonas aeruginosa by the boronic acid SM23 320
Design, synthesis, crystal structures and antimicrobial activity of sulfonamide boronic acids as beta-lactamase inhibitors 318
Fragment-guided Design of Subnanomolar β-Lactamase Inhibitors Active in vivo 315
Sintesi Stereoselettiva di Acidi Boronici Inibitori di beta-Lattamasi 310
Enantiomeric excess of 1,2-diols by formation of cyclic boronates: an improved method 301
One-Pot Synthesis of Imidazole-4-Carboxylates by Microwave-Assisted1,5-Electrocyclization of Azavinyl Azomethine Ylides 300
The β-lactamase Inhibitor Boronic Acid SM23 Inhibits Pseudomonas aeruginosa Biofilm Formation and Virulence Factor Production 299
Nanomolar inhibitors of AmpC beta-lactamase 298
A comprehensive and contemporary “snapshot” of β-lactamases in carbapenem resistant Acinetobacter baumannii 291
Acido alfa-Acetammido-alfa-Fenilmetanboronico come Agente Derivatizzante Chirale per la Determinazione dell’Eccesso Enantiomerico di 1,2-Dioli 281
Negative Epistasis and Evolvability in TEM-1 β-Lactamase—The Thin Line between an Enzyme's Conformational Freedom and Disorder 275
Sulfonamido-substituted boronic acids as β-lactamase inhibitors for treatment of antibiotic-resistant bacterial infections 272
Design and exploration of novel boronic acid Inhibitors reveals important Interactions with a clavulanic acid-resistant sulfhydryl- variable (SHV) β‑ lactamase 269
Lipase-Catalyzed Resolution and Desymmetrization of 2-Hydroxymethylaziridines 266
α-Aminoester-Derived Imidazoles by 1,5-Electrocyclization of Azavinyl Azomethine Ylides 263
Highly enantioselective reduction of ethyl 4-chloro-3-oxobutanoate to L-and D-3-hydroxyesters with baker`s yeast 258
The structures of Ceftazidime and Its Transition State Analog in Complex with AmpC-beta-lactamase: Implication for Resistance Mutation and Inhibitor Design 258
Inhibition of Acinetobacter -Derived Cephalosporinase: Exploring the Carboxylate Recognition Site Using Novel β-Lactamase Inhibitors 255
Straightforward synthesis of chiral non-racemic α-boryl isocyanides 254
Exploring sequence requirements for C3/C4 carboxylate recognition in the Pseudomonas aeruginosa cephalosporinase: Insights into plasticity of the AmpC β-lactamase 250
Boronic Acid Transition State Inhibitors as Potent Inactivators of KPC and CTX-M β-Lactamases: Biochemical and Structural Analyses 249
The β-lactamase Inhibitor Boronic Acid SM23 as a new anti-Pseudomonas aeruginosa Biofilm Compound 245
A method of treating a bacterial infection in a subject in need thereof includes administering to the subject therapeutically effective amts. of at least one β-lactam antibiotic and at least one triazolylmethyl boronic acid β-lactamase inhibitor. 242
Structure-based design and in-parallel synthesis of inhibitors of AmpC β-lactamase 237
Recognition and resistance in TEM beta-lactamase 234
Structure-based optimization of cephalotin analogue boronic acids as beta-lactamase inhibitors 234
Synthesis of [(1,2,3-Triazol-1-yl)methyl]boronic Acids Through Click Chemistry: Easy Access to a Potential Scaffold for Protease Inhibitors 232
Structure-Based Analysis of Boronic Acids as Inhibitors of Acinetobacter-Derived Cephalosporinase-7, a Unique Class C β-Lactamase 228
Using Boronic Acid Transition State Inhibitors to understand the extended spectrum (ES) and carbapenemase phenotypes of class A beta-lactamases in Klebsiella pneumoniae 218
Energetic, structural, and antimicrobial analyses of beta-lactam side chain recognition by beta-lactamases 211
α-Triazolylboronic Acids: A Promising Scaffold for Effective Inhibitors of KPCs 211
Exploring novel inhibitors of FOX-4 Class C β-lactamase 203
Inhibition of the Class C β-Lactamase from Acinetobacter spp.: Insights into Effective Inhibitor Design 203
Stereoselective synthesis of erythro beta-substituted aspartates 202
The role of a second-shell residue in modifying substrate and inhibitor interactions in the SHV β-lactamase: A study of Ambler position Asn276 200
Structures of FOX-4 cephamycinase in complex with transition-state analog inhibitors 198
Synthesis of a Novel Boronic Acid Transition State Inhibitor, MB076: A Heterocyclic Triazole Effectively Inhibits Acinetobacter-Derived Cephalosporinase Variants with an Expanded-Substrate Spectrum 186
Defining the minimum inhibitory concentration of 22 rifamycins in iron limited, physiologic medium against Acinetobacter baumannii, Escherichia coli, and Klebsiella pneumoniae clinical isolates 182
α‐Triazolylboronic Acids: A Novel Scaffold to Target FLT3 in AML 180
Structural Insights into Inhibition of the Acinetobacter-Derived Cephalosporinase ADC-7 by Ceftazidime and Its Boronic Acid Transition State Analog 177
Structure-Based Design and In Parallel Synthesis of Boronic Acid Inhibitors of AmpC 61538;-Lactamase 174
Sulfonamidoboronic Acids as “Cross-Class” Inhibitors of an Expanded-Spectrum Class C Cephalosporinase, ADC-33, and a Class D Carbapenemase, OXA-24/40: Strategic Compound Design to Combat Resistance in Acinetobacter baumannii 173
Structure-based design and solid phase synthesis of novel AmpC b-lactamase inhibitors 171
Progettazione, Sintesi ed Attività di Acidi 1-Acilamminoalcanboronici Inibitori di beta-Lattamasi 171
Interactions of Oxyimino-Substituted Boronic Acids and β-Lactams with the CMY-2-Derived Extended-Spectrum Cephalosporinases CMY-30 and CMY-42 169
Insights Into the Inhibition of MOX-1 β-Lactamase by S02030, a Boronic Acid Transition State Inhibitor 169
Boronate-Based Inhibitors of Penicillin-Binding Proteins: An Underestimated Avenue for Antibiotic Discovery? 153
Discovery of Boronic Acids-Based β-Lactamase Inhibitors Through In Situ Click Chemistry 146
Natural protein engineering in the Ω-loop: the role of Y221 in ceftazidime and ceftolozane resistance in Pseudomonas-derived cephalosporinase 115
Structural Studies of Inhibition of β-Lactamases by Boronic Acid Transition State Analogs and a Penam Sulfone 109
Restoring cefepime activity against multidrug-resistant KPC-producing Klebsiella pneumoniae by combination with boronic acid inhibitors, MB076 and S02030 108
Resistance to oxyimino-cephalosporins conferred by an alternative mechanism of hydrolysis by the Acinetobacter-derived cephalosporinase-33 (ADC-33), a class C β-lactamase present in carbapenem-resistant Acinetobacter baumannii (CRAb) 87
Totale 17.881
Salva come PNG Salva come JPEG
Categoria #
all - tutte 64.531
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 64.531
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.051 0 0 86 106 68 109 48 88 144 88 187 127
2022/20231.532 186 174 113 161 173 222 38 120 180 20 55 90
2023/2024988 38 76 49 104 186 92 143 78 26 32 53 111
2024/20253.060 110 65 70 178 536 456 205 228 301 84 337 490
2025/20266.283 376 334 587 784 876 516 665 232 532 621 417 343
2026/2027670 276 382 12 0 0 0 0 0 0 0 0 0
Totale 17.881